| mRNA |
Lisitinib |
GDSC1000 |
pan-cancer |
AAC |
0.0038 |
0.9 |
| mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.004 |
0.9 |
| mRNA |
neopeltolide |
CTRPv2 |
pan-cancer |
AAC |
0.0082 |
0.9 |
| mRNA |
purmorphamine |
CTRPv2 |
pan-cancer |
AAC |
-0.0044 |
0.9 |
| mRNA |
BRD-K20514654 |
CTRPv2 |
pan-cancer |
AAC |
0.006 |
0.9 |
| mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
-0.0041 |
0.9 |
| mRNA |
XL765 |
CTRPv2 |
pan-cancer |
AAC |
-0.0041 |
0.9 |
| mRNA |
Erlotinib |
FIMM |
pan-cancer |
AAC |
0.02 |
0.9 |
| mRNA |
CAY10576 |
CTRPv2 |
pan-cancer |
AAC |
-0.0043 |
0.9 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0038 |
0.9 |